| Literature DB >> 31409406 |
José Maria Gonçalves Fernandes1, Benício de Oliveira Romão2, Ivan Romero Rivera2, Maria Alayde Mendonça2, Francisco de Assis Costa3, Margareth de Souza Lira Handro4, Orlando Campos5, Ângelo Amato V De Paola5, Valdir Ambrósio Moisés5.
Abstract
AIMS: The Doppler-derived myocardial performance index (MPI) has been considered as a diagnostic and prognostic Doppler marker for many different clinical conditions. The purpose of this study was to determine the diagnostic accuracy of traditional Pulsed-wave Doppler (PWD-MPI) and Pulsed-wave tissue Doppler imaging (TDI-MPI) and the degree of agreement between these methods in patients with grade-I diastolic dysfunction (DDI) and a normal ejection fraction.Entities:
Keywords: Echocardiography, Doppler; Heart failure, diastolic; Hypertension; Ventricular function, left
Mesh:
Year: 2019 PMID: 31409406 PMCID: PMC6693095 DOI: 10.1186/s12947-019-0167-x
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Fig. 1Scheme for measurement of time intervals used to calculate the tissue Doppler-derived myocardial performance index (TDI-MPI): , time from cessation of the a’ wave to the onset of the e’ wave; , the duration of the S wave; c, interval between the R wave and onset of the e’ wave; d, interval between the R wave and cessation of the S wave; ICT, tissue Doppler-derived isovolumetric contraction time; IVRT
Clinical Profile and General Doppler Echocardiographic Findings
| Control | DDI Patients | 95% IC |
| |
|---|---|---|---|---|
| Age (yr) | 38 ± 10 | 65 ± 10 | 23 to 31 | < 0.001 |
| Male/female | 28/23 | 20/27 | 0.86 to 1.9 | 0.23 |
| Body surface area (m2) | 1.76 ± 0.18 | 1.68 ± 0.16 | 0.011 to 0.15 | 0.051 |
| Hypertension | – | 47 (100%) | ||
| Diabetes | – | 8 (17%) | ||
| Smoking | – | 5 (11%) | ||
| Dyslipidemia | – | 26 (55%) | ||
| Heart rate (bpm) | 66 ± 7.5 | 71 ± 8.6 | 2.62 to 8.9 | < 0.001 |
| SBP (mmHg) | 113 ± 16 | 154 ± 22 | 33 to 48 | < 0.001 |
| DBP (mmHg) | 67 ± 8.1 | 83 ± 13 | 10 to 19 | < 0.001 |
| Aortic root (mm) | 31 ± 2.9 | 33 ± 3.6 | 1.3 to 4.0 | < 0.001 |
| Left atrium (mm) | 30 ± 2.2 | 34 ± 4.0 | 2.7 to 5.3 | < 0.001 |
| LVDd (mm) | 46 ± 2.9 | 47 ± 3.0 | 0.52 to 2.7 | 0.004 |
| LVSd (mm) | 29.4 ± 2.5 | 30 ± 2.8 | −0.43 to 1.7 | 0.24 |
| Septal thickness (mm)* | 9.0 (7–10) | 12.0 (12–14) | < 0.001 | |
| RWT (cm) | 0.40 ± 0.03 | 0.52 ± 0.05 | 0.10 to 0.13 | < 0.001 |
| LV mass | 141 ± 31 | 226 ± 46 | 70 to 101 | < 0.0001 |
| LV mass index (g/m2) | 79 ± 12 | 134 ± 23 | 48 to 62 | < 0.001 |
| Fractional shortening (%) | 36 ± 3.5 | 36.4 ± 4.3 | −0.77 to 2.3 | 0.52 |
| Ejection fraction (%) | 65 ± 4.6 | 66 ± 5.4 | −1.02 to 3.11 | 0.33 |
| Medication | ||||
| ACE inhibitors/ARBs | 28 (60%) | |||
| Diuretics | 20 (43%) | |||
| Beta blockers | 15 (32%) | |||
| Calcium-channel blockers | 9 (19%) | |||
| Statins | 17 (36%) | |||
DDI, grade-I diastolic dysfunction patients; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVDD, left ventricular diastolic diameter; LVSD, left ventricular systolic diameter; PWT, posterior-wall thickness; RWT, relative wall thickness; ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker
Data expressed as mean ± standard deviation or median and 25-75th interquartile range
* Mann-Whitney test
Doppler Measurements in Both Study Groups (mean ± SD)
| Control | DDI Patients | 95% IC |
| |
|---|---|---|---|---|
| E wave (m/s) | 0.77 ± 0.16 | 0.62 ± 0.14 | 0.091 to 0.21 | < 0.001 |
| A wave (m/s) | 0.47 ± 0.09 | 0.82 ± 0.15 | −0.40 to - 0.30 | < 0.001 |
| E/A ratio | 1.67 ± 0.36 | 0.76 ± 0.10 | 0.80 to 1.0 | < 0.001 |
| DT (ms) | 164 ± 17 | 250 ± 38 | −97.6 to −74.1 | < 0.001 |
| S septal (cm/s) | 7.8 ± 1.2 | 6.3 ± 1.2 | 0.99 to 1.9 | < 0.001 |
| e’ septal (cm/s) | 10 ± 1.6 | 5.1 ± 1.3 | 4.6 to 5.7 | < 0.001 |
| a’ septal (cm/s) | 9.1 ± 1.3 | 10 ± 1.4 | −1.5 to - 0.43 | < 0.001 |
| e’/a’ septal | 1.1 ± 0.24 | 0.51 ± 0.12 | 0.56 to 0.72 | < 0.001 |
| E/e’ septal | 7.7 ± 1.5 | 13.1 ± 4.6 | −6.8 to −4.1 | < 0.001 |
| ET (ms) | 308 ± 19 | 308 ± 27 | −0.15 ± 4.6 | 0.98 |
| IVRT (ms) | 80 ± 17 | 105 ± 21 | −32 to − 17 | < 0.001 |
| ICT (ms) | 35 ± 17 | 32 ± 19 | − 4.7 to 9.5 | 0.51 |
| PWD-MPI | 0.37 ± 0.08 | 0.45 ± 0.11 | − 0.12 to − 0.036 | < 0.001 |
| S lateral (cm/s) | 11 ± 2.3 | 9.3 ± 2.1 | 0.39 to 2.2 | 0.006 |
| e’ lateral (cm/s) | 15 ± 3.2 | 8.3 ± 2.6 | 6.0 to 8.5 | < 0.001 |
| a’ lateral (cm/s) | 9.8 ± 2.2 | 13.6 ± 3.5 | −5.0 to −2.7 | < 0.001 |
| e’/a’ lateral | 1.7 ± 0.55 | 0.62 ± 0.19 | 0.87 to 1.2 | < 0.001 |
| E/e’ lateral | 5.2 ± 1.4 | 8.3 ± 3.6 | −4.2 to − 2.0 | < 0.001 |
| E/e’ average | 6.4 ± 1.4 | 10.8 ± 3.8 | −5.5 to − 3.2 | < 0.001 |
| t-ET (ms) | 317 ± 20 | 314 ± 28 | − 6.6 to 13.2 | 0.51 |
| t-IVRT (ms) | 76 ± 19 | 109 ± 27 | − 43 to − 24 | < 0.001 |
| TDI-MPI | 0.40 ± 0.09 | 0.49 ± 0.14 | − 0.13 to − 0.035 | < 0.001 |
DDI, grade-I diastolic dysfunction patients; DT, deceleration time of the E wave; S, peak systolic annular velocity; e’, early mitral annulus diastolic velocity; a’, late diastolic velocity; E/e’, relationship between the velocity of the early mitral filling E wave and the e’ wave; ET, ejection time; ICT, isovolumetric contraction time; IVRT, isovolumetric relaxation time; MPI, myocardial performance index; t-ET, tissue Doppler-derived ejection time; t-IVRT, tissue Doppler-derived isovolumetric relaxation time; t-ICT, tissue Doppler-derived isovolumetric contraction time; TDI-MPI, pulsed-wave tissue Doppler-derived myocardial performance index
Univariate and Multiple Regression Analysis of TDI-MPI
| Univariate Analysis | Multiple Analysis | |||
|---|---|---|---|---|
| r |
|
|
| |
| LV mass | 0.39 | 0.006 | 0.325 | 0.031 |
| S septal | - 0.38 | 0.009 | - 0.332 | 0.058 |
| e’ septal | - 0.41 | 0.004 | 0.092 | 0.78 |
| e’/a’ septal | - 0.36 | 0.014 | ||
| E/e’ septal | 0.36 | 0.012 | ||
E early mitral filling wave, S peak systolic annular velocity, e early mitral annulus diastolic velocity, a late diastolic velocity
R = 0.304; Adjusted R = 0.219; standard error of estimate = 0.124
β = Standardized coefficient; r = Pearson correlation
Fig. 2The areas under the ROC curves and the corresponding 95% confidence intervals for (a) tissue Doppler-derived myocardial performance index (TDI-MPI) and (b) conventional Doppler-derived myocardial performance index (PWD-MPI)
Measures of TDI-MPI and PWD-MPI for the diagnosis of diastolic dysfunction
| TDI-MPI (Cut-off point > 0.42) | PWD-MPI (Cut-off point > 0.40) |
| |
|---|---|---|---|
| Accuracy (%; 95% CI) | 67 (58 to 76) | 66 (57 to 75) | 0.91 |
| Sensitivity (%; 95% CI) | 74 (60 to 86) | 64 (50 to 76) | 0.37 |
| Specificity (%; 95% CI) | 61 (46 to 74) | 69 (55 to 80) | 0.53 |
| PPV (%; 95% CI) | 64 (50 to 75) | 65 (51 to 77) | 0.91 |
| NPV (%; 95% CI) | 72 (57 to 83) | 67 (54 to 78) | 0.75 |
| (+) LLR (95% CI) | 1.90 (1.30 to 2.8) | 2.0 (1.3 to 3.2) | |
| (−) LLR (95% CI) | 0.42 (0.25 to 0.72) | 0.53 (0.35 to 0.80) |
MPI myocardial performance index, PPV positive predictive value, NPV negative predictive value; (+) LLR positive likelihood ratio; (−)LLR negative likelihood ratio
Fig. 3Comparison of the areas under the ROC curves for tissue Doppler-derived myocardial performance index (TDI-MPI) and conventional Doppler-derived Myocardial Performance Index (PWD-MPI)
Fig. 4Bland-Altman plot of the differences between TDI-MPI and PWD-MPI for control group and DDI patients